Biocon is India’s largest and fully integrated biopharmaceutical company. The company has extensive services across small molecules, biologics, and biosimilars, serving clients in 120 countries. Biocon also has a robust portfolio of generic APIs and small molecule drug substances, specializing in statins, immunosuppressants, and other specialty products. The company’s services encompass generic formulations, manufacturing, R&D, and regulatory affairs.